135 related articles for article (PubMed ID: 37925677)
1. Efficacy and safety of calcipotriol as a potential topical treatment of acne vulgaris: a randomized, controlled, triple blinded, split-face clinical trial.
Mahran A; Ghazally A; Ali AS; Bakr RM
Clin Exp Dermatol; 2024 Mar; 49(4):348-355. PubMed ID: 37925677
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol: A novel tool in treatment of acne vulgaris.
Abdel-Wahab HM; Ali AK; Ragaie MH
Dermatol Ther; 2022 Sep; 35(9):e15690. PubMed ID: 35789164
[TBL] [Abstract][Full Text] [Related]
3. Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).
Chayahara N; Mukohara T; Tachihara M; Fujishima Y; Fukunaga A; Washio K; Yamamoto M; Nakata K; Kobayashi K; Takenaka K; Toyoda M; Kiyota N; Tobimatsu K; Doi H; Mizuta N; Marugami N; Kawaguchi A; Nishigori C; Nishimura Y; Minami H
Oncologist; 2019 Jul; 24(7):885-e413. PubMed ID: 30890624
[TBL] [Abstract][Full Text] [Related]
4. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Kerrouche N; Tan J
Am J Clin Dermatol; 2018 Apr; 19(2):275-286. PubMed ID: 29549588
[TBL] [Abstract][Full Text] [Related]
5. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Ioannides D; Rigopoulos D; Katsambas A
Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
[TBL] [Abstract][Full Text] [Related]
6. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
7. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
8. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Thiboutot D; Arsonnaud S; Soto P
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
[TBL] [Abstract][Full Text] [Related]
10. Comparison Of Efficacy Of Topical Adapalene Plus Oral Azithromycin And Topical Adapalene Plus Oral Doxycycline In Treatment Of Acne Vulgaris.
Ullah G; Ali F; Paracha MM; Noor SM; Naeem J
J Ayub Med Coll Abbottabad; 2022; 34(4):782-785. PubMed ID: 36566399
[TBL] [Abstract][Full Text] [Related]
11. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
Capizzi R; Landi F; Milani M; Amerio P
Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
[TBL] [Abstract][Full Text] [Related]
12. A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel.
Chularojanamontri L; Tuchinda P; Kulthanan K; Varothai S; Winayanuwattikun W
J Dermatolog Treat; 2016; 27(2):140-5. PubMed ID: 26293170
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.
Zheng Y; Yin S; Xia Y; Chen J; Ye C; Zeng Q; Lai W
Cutan Ocul Toxicol; 2019 Mar; 38(1):48-54. PubMed ID: 30173582
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
[TBL] [Abstract][Full Text] [Related]
15. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
Pariser D; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
[TBL] [Abstract][Full Text] [Related]
16. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
17. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study.
Kawashima M; Harada S; Loesche C; Miyachi Y
J Dermatol Sci; 2008 Mar; 49(3):241-8. PubMed ID: 18063345
[TBL] [Abstract][Full Text] [Related]
18. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA
Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160
[TBL] [Abstract][Full Text] [Related]
20. Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Eichenfield LF; Stein Gold L; Kircik LH; Werschler WP; Beer K; Draelos ZD; Tanghetti EA; Papp KA; Baldwin H; Lain E; Sadick N; Gooderham MJ; Konda A
Pediatr Dermatol; 2023; 40(3):452-459. PubMed ID: 36949579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
